Redcare Phamacy Unsp/Adr

Yes, thank you very much, and good morning, everybody, and a very warm welcome from my side. Let's have a look into today's agenda. So we would like to first start with financial performance, then an update on business strategy, and then by the end, outlook and guidance. Let's start with the financial performance first. So Q1 2024 highlights. We continue really strong, very strong sales growth, including medic service, we are up 51%, but also organic growth, excluding medic service, shows a strong 90% growth. Also, if you look into the non-Rx growth, we are at 20%. And you know, for an online company and also an online pharmacy, it's always important to make the jump at the beginning of the year, and that is always a result of the which we have been built over the past, plus our capabilities to bring in new customers at the beginning of the year, and we are really happy that we achieved that jump to 20%. As you all know, the eRAC became mandatory beginning of 2024 in Germany, and we saw a great adoption rate of above 75% all of the scripts being e-scripts. And because of that, we already increased our marketing activities in Q1. And we did this to make sure that in the transition from paper to e-scripts, we keep our existing customers. And at the same time, of course, we also wanted to learn how to acquire new customers and convert also existing OTC and BTT customers. As a result of that, we ended up in the 2.1% adjusted EBITDA margin, being up 33% compared to last year. If we go to the next slide, you can see that our strong growth continues in both of our reporting segments. I mean, for sure, we can see in DACH that that's driven by Mediservice because the huge increase because we only consolidated Mediservice last year in May. Phamacy Unsp & Adr Phamacy Unsp

Can we go to the next slide, please? And this is also reflected in the number of active customers. You can see here we added an 0.4 million active customers in Q1, and now adding up on 11.2 million active customers. And also, if we look into the net promoter score, I mean, we are able to keep this at 70. And to us, this is not just a number. To us, this is the most relevant KPI we have in our company. And so therefore, we are proud of that we can continue to be high on that NPS. Also very good news on the average basket size. It's up compared to the first quarter of last year. And of course, this will also help our P&L. If we go to the next slide, you see that the jump up I described earlier in sales, I mean, we also see it in orders here. Right now we are processing almost 100,000 orders a day from our warehouses on average and still we keep that very high NPS of 70 and also again the repeat rate is at 87% so confirming our healthy customer file. I would like now to hand over to Jasper.

Yeah Olaf, thanks very much and good morning to everybody also from my side and I'm happy to present the numbers of the As Olav already shared with you on the prior slides, we achieved new records as to the number of orders in quarter one. So quarter one was even up from the strong quarter four that we had. And that's what we also see in column two, three, and four of this table, because that's the quarter over quarter comparison. The good thing is in both quarters, maybe service was Phamacy Unsp & Adr So it's a bit of an apple and orange because of seasonality, but still looking through it from a helicopter view. Actually, our gross profit margin was slightly higher than it was in the fourth quarter. Our total S&D and A as a percentage of sales was slightly up seasonality, but also impact of what Olaf referred to already, some additional communication after we saw the very rapid increase of ERX in Germany. So we took that momentum. All in all, 12 million adjusted EBDA in the past quarter. If we then go to column four, five, and six, so the year-over-year comparison, Q1 last year compared to this year, from seasonality perspective, virtually comparable. There's a slight shift in Easter, but that's going towards only rounding. But of course, last year, May e-service was not included yet. Phamacy Unsp & Adr Phamacy Unsp & Adr Phamacy Unsp lower than the prior year, but with the fast sales growth and this margin, we generated a couple of million more adjusted EBITDA in absolute terms. So 3 million up in adjusted EBITDA, and for clarity's sake, as always, the fully loaded EBITDA also there, and that did increase even by 6 million, reflective of the fact that our adjustment went down from 4 to just slightly above 1 million this quarter. The gross margin year-over-year, minus 4.3%, the cost performance plus 4.1%. Simply said, it's only mixed because of main service. And for that reason, on the next slide, we give this clarity. And here you see the gross profit margin. And on the left side, you first see the 27.7% going down. But if you take the apple-to-apple comparison, that actually, and we are very happy compared to last year. So the gross profit margin increased in combination with the very fast increase of our sales. So very good, much more gross profit in absolute euros. We can go to the next slide. So here it's the same representation. The first two columns are made apple to apple, so that is excluding many services of this year. And you see there a slight increase only of around 0.3 to 0.4%. Phamacy Unsp & Adr we as a company have been able to fully offset those cost invasions with structural efficiency, both in operations and in marketing. So the year-over-year cost performance was slightly stable, was more or less stable, despite that situation. Of course, there was also, and then I go to the cash flow slide, but you can keep the slide on, help in the overall P&L was not only efficiency, but also the slightly increased basket is very good to our unit economics. Cash flow here, very nice, an increase of 15 million to already tell you the conclusion. It's mainly because of seasonality that we were benefiting from an increased payable balance as we generally see each quarter and last year even more than we So I'll walk through the bridge. It's a total of cash, as you can find on the balance, and other short-term financial assets, so our fixed deposits, which we also consider cash. So it's slightly above 200 million when we started the year. We had a positive adjusted EBITDA off here from a cash perspective, 11 million. We had working capital improvements of 17 million. We had investments of around 9 million, and we had